ArticleOncotarget2016

Upregulation of SIRT6 predicts poor prognosis and promotes metastasis of non-small cell lung cancer via the ERK1/2/MMP9 pathway.

Lihong Bai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.